Quantum-dots-based detection of hepatitis C virus (HCV) NS3 using RNA aptamer on chip

Journal of Chemical Technology and Biotechnology

Volumn 85, Issue 8, 2010, Pages 1130-1134

  Roh, Changhyun ^a   Lee, Ho Young ^b   Kim, Sang Eun ^b   Jo, Sung Kee ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Diagnosis; Hepatitis C virus (HCV); Imaging; Nanoparticle; Quantum dots (QDs); RNA aptamer

Indexed keywords

HEPATITIS C VIRUS; HEPATITIS C VIRUS (HCV); QUANTUM DOTS; QUANTUM DOTS (QDS); RNA APTAMER;

ASSAYS; DIAGNOSIS; NANOPARTICLES; OLIGONUCLEOTIDES; POLYPEPTIDES; POPULATION STATISTICS; PROBES; PROTEINS; RNA; SEMICONDUCTOR QUANTUM DOTS; STRATEGIC PLANNING; VIRUSES;

COMPUTER VIRUSES;

APTAMER; CARBOXYL GROUP; NANOPARTICLE; NONSTRUCTURAL PROTEIN 3; QUANTUM DOT; RNA;

ARTICLE; BIOCHIP; BRIGHTNESS; FLUORESCENCE; FLUORESCENCE ANALYSIS; HEPATITIS C VIRUS; IMAGING SYSTEM; NONHUMAN; PROTEIN ANALYSIS;

HEPATITIS C VIRUS;

EID: 77955347800     PISSN: 02682575     EISSN: 10974660     Source Type: Journal    
DOI: 10.1002/jctb.2409     Document Type: Article

References (29)

1. Bonino F, Effect of interferon on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 23:1535-1539 (1998). (Pubitemid 28230887)
2. Nishiguchi S, Shiomi S, Nakatani S, Takeda T, Fukuda K and Tamori A, Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet 357:196-197 (2001). (Pubitemid 32108094)
3. Butt AA, Wang X and Moore CG, Effect of hepatitis C virus and its treatment on survival. Hepatology 50:387-392 (2009).
4. Uto H, Stuver SO, Hayashi K, Kumagai K, Sasaki F, and Kanmura S, et al, Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology 50:393-399 (2009).
5. Elizabeth KW, Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification. Hepatology 50:349-351 (2009).
6. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, and Fujita J, et al, Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 65:1105-1113 (1991).
7. Choo QL, Richman KH, Han JH, Berger, K., Lee C, and Dong C, et al, Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci 88:2451-2455 (1991).
8. Kwong AD, Kim JL and Lin C, Structure and function of hepatitis C virus NS3 helicase. Curr Top Microbiol Immunol 242:171-196 (2000).
9. Jayasena SD, Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45:1628-1650 (1999).
10. Tuerk C and Gold L, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-510 (1990). (Pubitemid 20248891)
11. Bock LC, Griffin LC, Latham JA, Vermaas EH and Toole JJ, Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355:564-566 (1992).
12. Lorsch JR and Szostak JW, In vitro selection of RNA aptamers specific for cyanocobalamin. Biochemistry 33:973-982 (1994).
13. Burgstaller P, Girod A and Blind M, Aptamers as tools for target prioritization and lead identification. Drug Discov Today 7:1221-1228 (2002). (Pubitemid 35472039)
14. Gold L, Allen P, Binkley J, Brown D, Schneider D, and Eddy SR, et al, RNA: the shape of things to come, in The RNA World, ed by Gestelend RF and Atkins JF. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 497-510 (1993).
15. Hwang B, Cho JS, Yeo HJ, Kim JH, Chung KM, and Han K, et al, Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus. RNA 10:1277-1290 (2004). (Pubitemid 38989013)
16. Cho S, Kim JE, Lee BR and Kim BG, Biaptazyme sensors for hepatitis C virus replicase and helicase without blank signal. Nucl Acid Res 33:e177 (2005).
17. Alivisatos P, The use of nanocrystals in biological detection. Nat Biotechnol 22:47-52 (2004).
18. Fortina P, Kricka LJ, Surrey S and Grodzinski P, Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 23:168-173 (2005). (Pubitemid 40381278)
19. Pinaud F, King D, Moore HP and Weiss S, Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelating-related peptides. J Am Chem Soc 126:6115-6123 (2004). (Pubitemid 38637980)
20. Jun T, Bochu W and Liancai Z, Quantum dots: a novel tool to discovery. Pak J Biol Sci 9:917-922 (2006). (Pubitemid 43938309)
21. William WY, Chang E, Drezek R and Colvin VL, Water-soluble quantum dots for biomedical applications. Biochem Biophys Res Commun 348:781-786 (2006). (Pubitemid 44233496)
22. Kim YG, Moon S, Kuritzkes DR and Demirci U, Quantum dot-based HIV capture and imaging in a microfluidic channel. Biosens Bioelectron 25:253-258 (2009).
23. Ko MH, Kim S, Kang WJ, Lee JH, Kang H, and Moon SH, et al, In vitro derby imaging of cancer biomarkers using quantum dots. Small 5:1207-1212 (2009).
24. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685 (1970).
25. Bradford M, A Rapid and Sensitive Method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 72:248-254 (1976).
26. Lee Y, Lee EK, Cho YW, Matsui T, Kang IC, and Kim TS et al, ProteoChip: a highly sensitive protein microarray prepared by a novel methodof protein immobilization for application of protein-protein interaction studies. Proteomics 3:2289-2304 (2003). (Pubitemid 38010106)
27. Poiakov A, Hubatsch I, Shuman CF, Stenberg G and Danielson UH, Expression and purification of recombinant full-length NS3 protease-helicase from a new variant of hepatitis C virus. Prot Express Purif 25:363-371 (2002). (Pubitemid 35293963)
28. Sarrazin C, Kieffer TL, Bartels D, Hanzelka B, Muh U, and Welker M, et al, Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterol 132:1767-1777 (2007).
29. Lamarre D, Anderson PC, Bailey M, et al, An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426:186-189 (2003). (Pubitemid 36799238)